Economics at your fingertips  

Exploring the relative value of end of life QALYs: Are the comparators important?

Neil McHugh, José Luis Pinto-Prades, Rachel Baker, Helen Mason and Cam Donaldson

Social Science & Medicine, 2020, vol. 245, issue C

Abstract: In the UK, life extending, end-of-life (EoL) treatments are an exception to standard cost-per-quality-adjusted life year (QALY) thresholds. This implies that greater value is placed on gaining these QALYs, than QALYs gained by the majority of other patient groups treated for anything else in the health system, even for other EoL contexts (such as quality of life (QoL) improvements alone). This paper reports a Person Trade-Off (PTO) study to test whether studies that find societal support for prioritising EoL life extensions can be explained by the severity, in terms of prospective QALYs loss, of the non-terminal comparator scenarios.

Keywords: End-of-life; Life extension; Person trade-off; Comparators; Stated preferences; UK (search for similar items in EconPapers)
Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed

Downloads: (external link)
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link:

Ordering information: This journal article can be ordered from
http://www.elsevier. ... _01_ooc_1&version=01

DOI: 10.1016/j.socscimed.2019.112660

Access Statistics for this article

Social Science & Medicine is currently edited by Ichiro (I.) Kawachi and S.V. (S.V.) Subramanian

More articles in Social Science & Medicine from Elsevier
Bibliographic data for series maintained by Haili He ().

Page updated 2020-05-16
Handle: RePEc:eee:socmed:v:245:y:2020:i:c:s0277953619306550